Alerts will be sent to your verified email
Verify Email
CHCL
|
Cian Healthcare
|
Beryl Drugs
|
Unjha Formulations
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
-2.49 % | 2.54 % | 11.14 % |
|
5yr average Equity Multiplier
|
2.79 | 2.23 | 1.74 |
|
5yr Average Asset Turnover Ratio
|
0.42 | 1.08 | 3.48 |
|
5yr Avg Net Profit Margin
|
-2.06 % | 0.66 % | 1.88 % |
|
Price to Book
|
0.0 | 1.05 | 3.19 |
|
P/E
|
40.69 | 16.49 | 25.33 |
|
5yr Avg Cash Conversion Cycle
|
-692.15 Days | -619.24 Days | 14.25 Days |
|
Inventory Days
|
163.23 Days | 36.1 Days | 26.1 Days |
|
Days Receivable
|
131.14 Days | 98.89 Days | 26.23 Days |
|
Days Payable
|
473.59 Days | 969.29 Days | 63.08 Days |
|
5yr Average Interest Coverage Ratio
|
0.8 | 1.68 | 5.17 |
|
5yr Avg ROCE
|
5.59 % | 5.73 % | 20.73 % |
|
5yr Avg Operating Profit Margin
|
14.07 % | 7.19 % | 2.93 % |
|
5 yr average Debt to Equity
|
1.12 | 0.64 | 0.0 |
|
5yr CAGR Net Profit
|
n/a | 72.78 % | -2.02 % |
|
5yr Average Return on Assets
|
-0.86 % | 1.31 % | 6.49 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
27.1 % | 26.38 % | 36.92 % |
|
Share Pledged by Promoters
|
34.48 % | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
-43.79 % | 1.46 % | 0.0 |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |